Orchid gets US FDA nod for three Cefuroxime Inj ANDAs (PharmaBiz)
The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals, has received approvals from the US FDA for three of its ANDAs (Abbreviated New Drug Application) for Cefuroxime for Injection, 750 mg & 1.5 g vials (infusion packs), 7.5 g (pharmacy bulk pack) and 1.5 g vial.

St. Jude Medical Announces U.S. And European Approval Of Angio-Seal Evolution Vascular Closure Device (Medical News Today)
St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device. The approval and global launch was announced at the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C.

Orchid Chemicals receives ANDA approval (Business Standard India)
Chennai-based pharma major, Orchid Chemicals and Pharmaceuticals announced that it has received approvals from the US Food and Drug Administration (US FDA for three of its Abbreviated New Drug Application (ANDA) for Cefuroxime for Injection, 750 mg and 1.5 g vials (infusion packs), 7.5 g (pharmacy bulk pack) and 1.5 g vial.